期刊
JOURNAL OF PEDIATRIC ONCOLOGY NURSING
卷 34, 期 1, 页码 5-12出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/1043454216659448
关键词
immunotherapy; infusion management; patient safety
Therapy combining dinutuximab with granulocyte macrophage colony stimulating factor, interleukin 2, and isotretinoin has significant side effects; however, these complications are generally predictable and can be managed proactively.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据